Доступ предоставлен для: Guest
Critical Reviews™ in Immunology

Выходит 6 номеров в год

ISSN Печать: 1040-8401

ISSN Онлайн: 2162-6472

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.3 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.6 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00079 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.24 SJR: 0.429 SNIP: 0.287 CiteScore™:: 2.7 H-Index: 81

Indexed in

Dendritic Cell-Based Immunotherapy of Prostate Cancer

Том 18, Выпуск 1-2, 1998, pp. 109-119
DOI: 10.1615/CritRevImmunol.v18.i1-2.120
Get accessGet access

Краткое описание

The immunotherapy of cancer, based on eliciting or enhancing the body’s own capacity to mount an effective antitumor response, has produced encouraging early results in the areas of melanoma and renal-cell carcinoma. Such treatments utilizing dendritic cells (DC), immune cells that are excellent antigen presenters, are especially promising. We performed a phase I clinical trial assessing the administration of autologous DC pulsed with HLA-A0201 -specific prostate-specific membrane antigen (PSMA) for the treatment of 51 men with hormone-refractory prostate cancer. Participants were divided into five groups receiving four or five infusions of peptides alone (PSM-P1 or PSM-P2; group 1 and 2, respectively), autologous DC (group 3), or DC pulsed with PSM-P1 or P2 (group 4 and 5, respectively). No significant toxicity was observed. Immune reactivity against PSM-P2 was detected in HLA-A2+ patients infused with DC pulsed with PSM-P1 or -P2 (group 4 and 5). An average decrease in PSA was observed only in group 5. Seven partial responders were identified based on NPCP criteria + PSA. The excellent tolerance of this treatment approach, as well as the enhanced cellular responses, decreased PSA levels, and partial clinical responses in some patients suggests that it holds great potential in prostate cancer therapy.

Ключевые слова: T cell, phase I trial, therapy, carcinoma, human.
ЦИТИРОВАНО В
  1. Lee Wei-Chen, Wang Hui-Chuan, Hung Chien-Fu, Huang Pei-Fang, Lia Chen-Rong, Chen Miin-Fu, Vaccination of Advanced Hepatocellular Carcinoma Patients with Tumor Lysate-Pulsed Dendritic Cells, Journal of Immunotherapy, 28, 5, 2005. Crossref

  2. Siemens D. Robert, Ratliff Timothy L., Are Vaccinations for Prostate Cancer Realistic?, in Prostate Cancer, 2003. Crossref

  3. BLANCO PATRICK, PALUCKA A. KAROLINA, BANCHEREAU JACQUES, Introduction to Dendritic Cells, in Gene Therapy of Cancer, 2002. Crossref

  4. Davis Ian D, An overview of cancer immunotherapy, Immunology and Cell Biology, 78, 3, 2000. Crossref

  5. Dietz Allan B., Bulur Peggy A., Erickson Michele R., Wettstein Peter J., Litzow Mark R., Wyatt William A., Dewald Gordon W., Tefferi Ayelew, Pankratz V. Shane, Vuk-Pavlovic Stanimir, Optimizing Preparation of Normal Dendritic Cells andbcr-abl+Mature Dendritic Cells Derived from Immunomagnetically Purified CD14+Cells, Journal of Hematotherapy & Stem Cell Research, 9, 1, 2000. Crossref

  6. Burch Patrick A., Croghan Gary A., Gastineau Dennis A., Jones Lori A., Kaur Judith S., Kylstra Jelle W., Richardson Ronald L., Valone Frank H., Vuk-Pavlović Stanimir, Immunotherapy (APC8015, Provenge®) targeting prostatic acid phosphatase can induce durable remission of metastatic androgen-independent prostate cancer: A phase 2 trial, The Prostate, 60, 3, 2004. Crossref

  7. McKenzie Ian FC, Apostolopoulos Vasso, Plebanski Magdalena, Pietersz Geoffrey A, Loveland Bruce E, Aspects of cancer immunotherapy, Immunology & Cell Biology, 81, 1, 2003. Crossref

  8. Granziero Luisa, Krajewski Stanislaw, Farness Peggy, Yuan Lunli, Courtney Michele K., Jackson Michael R., Peterson Per A., Vitiello Antonella, Adoptive immunotherapy prevents prostate cancer in a transgenic animal model, European Journal of Immunology, 29, 4, 1999. Crossref

  9. Iwase Shigeru, Tsujimura Kunio, Matsudaira Yasue, Ozeki Satoshi, Onozaki Kikuo, Obata Yuichi, Takahashi Toshitada, Comparison of Anti-Tumor Responses against TL Positive Lymphoma Induced by Skin Grafting and Dendritic Cell Immunization, Microbiology and Immunology, 44, 7, 2000. Crossref

  10. Gao Xiang, Honn Kenneth V., Chapter 4 Tumor markers for prostate cancer, in The Oncobiology of the Prostate, 3, 1999. Crossref

  11. Balkow Sandra, Loser Karin, Krummen Mathias, Higuchi Tetsuya, Rothoeft Tobias, Apelt Jenny, Tuettenberg Andrea, Weishaupt Carsten, Beissert Stefan, Grabbe Stephan, Dendritic cell activation by combined exposure to anti-CD40 plus interleukin (IL)-12 and IL-18 efficiently stimulates anti-tumor immunity, Experimental Dermatology, 18, 1, 2009. Crossref

  12. Yamaguchi Shinjiro, Tatsumi Tomohide, Takehara Tetsuo, Sakamori Ryotaro, Uemura Akio, Mizushima Tsunekazu, Ohkawa Kazuyoshi, Storkus Walter J., Hayashi Norio, Immunotherapy of murine colon cancer using receptor tyrosine kinase EphA2-derived peptide-pulsed dendritic cell vaccines, Cancer, 110, 7, 2007. Crossref

  13. Cai Quan, Kublo Lyubov, Cumberland Rachel, Gooding William, Baar Joseph, Optimized Systemic Dosing with CpG DNA Enhances Dendritic Cell-Mediated Rejection of a Poorly Immunogenic Mammary Tumor in BALB/c Mice, Clinical and Translational Science, 2009. Crossref

  14. Di Nicola Massimo, Carlo-Stella Carmelo, Anichini Andrea, Mortarini Roberta, Guidetti Anna, Tragni Gabrina, Gallino Francesco, Del Vecchio Michele, Ravagnani Fernando, Morelli Daniele, Chaplin Paul, Arndtz Nathaly, Sutter Gerd, Drexler Ingo, Parmiani Giorgio, Cascinelli Natale, Gianni Alessandro M., Immunization of Patients with Malignant Melanoma with Autologous CD34+Cell-Derived Dendritic Cells TransducedEx Vivowith a Recombinant Replication-Deficient Vaccinia Vector Encoding the Human Tyrosinase Gene: A Phase I Trial, Human Gene Therapy, 14, 14, 2003. Crossref

  15. Salgaller Michael L, Prostate cancer immunotherapy at the dawn of the new millennium, Expert Opinion on Investigational Drugs, 9, 6, 2000. Crossref

  16. Jones Lori A, Salgaller Michael L, Immunologic approaches to antigen discovery for cancer vaccines, Expert Opinion on Investigational Drugs, 9, 3, 2000. Crossref

  17. Tatsumi Tomohide, Takehara Tetsuo, Yamaguchi Shinjiro, Sasakawa Akira, Sakamori Ryotaro, Ohkawa Kazuyoshi, Kohga Keisuke, Uemura Akio, Hayashi Norio, Intrahepatic delivery of α-galactosylceramide-pulsed dendritic cells suppresses liver tumor, Hepatology, 45, 1, 2007. Crossref

  18. Cai Quan, Kublo Lyubov, Cumberland Rachel, Gooding William, Baar Joseph, Optimized Systemic Dosing with CpG DNA Enhances Dendritic Cell-Mediated Rejection of a Poorly Immunogenic Mammary Tumor in BALB/c Mice, Clinical and Translational Science, 2, 1, 2009. Crossref

  19. Lathers Deanne M.R., Clark Joseph I., Achille Nicholas J., Young M.Rita I., Phase IB study of 25-hydroxyvitamin D3 treatment to diminish suppressor cells in head and neck cancer patients, Human Immunology, 62, 11, 2001. Crossref

  20. Berlyn Kathleen A., Schultes Birgit, Leveugle Beatrice, Noujaim Antoine A., Alexander Richard B., Mann Dean L., Generation of CD4+ and CD8+ T Lymphocyte Responses by Dendritic Cells Armed with PSA/Anti-PSA (Antigen/Antibody) Complexes, Clinical Immunology, 101, 3, 2001. Crossref

  21. Scott-Taylor T.H., Pettengell R., Clarke I., Stuhler G., La Barthe M.C., Walden P., Dalgleish A.G., Human tumour and dendritic cell hybrids generated by electrofusion: potential for cancer vaccines, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1500, 3, 2000. Crossref

  22. Oehler Leopold, Berer Andrea, Keil Felix, Weinländer Georg, König Margit, Haas Oskar A., Lechner Klaus, Geissler Klaus, Generation of Dendritic Cells from Human Chronic Myelomonocytic Leukemia Cells in Fetal Calf Serum-Free Medium, Leukemia & Lymphoma, 38, 5-6, 2000. Crossref

  23. Ferrer Fernando A., Rodriguez Ronald, PROSTATE CANCER GENE THERAPY, Hematology/Oncology Clinics of North America, 15, 3, 2001. Crossref

  24. Nouri-Shirazi Mahyar, Banchereau Jacques, Fay Joseph, Palucka Karolina, Dendritic cell based tumor vaccines, Immunology Letters, 74, 1, 2000. Crossref

  25. Bremers A.J.A, Kuppen P.J.K, Parmiani G, Tumour immunotherapy: the adjuvant treatment of the21st century?, European Journal of Surgical Oncology (EJSO), 26, 4, 2000. Crossref

  26. Bremers Andreas J.A, Parmiani Giorgio, Immunology and immunotherapy of human cancer: present concepts and clinical developments, Critical Reviews in Oncology/Hematology, 34, 1, 2000. Crossref

  27. Rodriguez Ronald, Simons Jonathan W, Urologic applications of gene therapy, Urology, 54, 3, 1999. Crossref

  28. Mitchell Duane A., Sampson John H., Toward effective immunotherapy for the treatment of malignant brain tumors, Neurotherapeutics, 6, 3, 2009. Crossref

  29. Broghammer Elizabeth L., Ratliff Timothy L., Immunotherapy of urologic tumors, Urologic Oncology: Seminars and Original Investigations, 7, 2, 2002. Crossref

  30. Lubaroff David M., Karan Dev, CpG oligonucleotide as an adjuvant for the treatment of prostate cancer, Advanced Drug Delivery Reviews, 61, 3, 2009. Crossref

  31. Lowenfeld Lea, Zaheer Salman, Oechsle Crystal, Fracol Megan, Datta Jashodeep, Xu Shuwen, Fitzpatrick Elizabeth, Roses Robert E., Fisher Carla S., McDonald Elizabeth S., Zhang Paul J., DeMichele Angela, Mick Rosemarie, Koski Gary K., Czerniecki Brian J., Addition of anti-estrogen therapy to anti-HER2 dendritic cell vaccination improves regional nodal immune response and pathologic complete response rate in patients with ERpos/HER2pos early breast cancer, OncoImmunology, 6, 9, 2017. Crossref

  32. Goxe B., Latour N., Chokri M., Abastado J. P., Salcedo M., Simplified Method to Generate Large Quantities of Dendritic Cells Suitable for Clinical Applications, Immunological Investigations, 29, 3, 2000. Crossref

  33. Bedrosian Isabelle, Roros James G., Xu Shuwen, Nguyen Hung Q., Engels Friederike, Faries Mark B., Koski Gary K., Cohen Peter A., Czerniecki Brian J., Granulocyte-Macrophage Colony-Stimulating Factor, Interleukin-2, and Interleukin-12 Synergize With Calcium Ionophore to Enhance Dendritic Cell Function, Journal of Immunotherapy, 23, 3, 2000. Crossref

  34. Hori Shin-ichi, Heike Yuji, Takei Masao, Maruyama Midori, Inoue Yoshiko, Lee Je-Jung, Kim Hyeoung-Joon, Harada Yukie, Kawai Hiroyuki, Shimosaka Akihiro, Kami Masahiro, Tanosaki MD Ryuji, Wakasugi Hiro, Saito Shigeru, Takaue Yoichi, Kakizoe Tadao, Freeze-Thawing Procedures Have No Influence on the Phenotypic and Functional Development of Dendritic Cells Generated from Peripheral Blood CD14+ Monocytes, Journal of Immunotherapy, 27, 1, 2004. Crossref

  35. Zhang Jin-Kun, Antitumor activities of human dendritic cells derived from peripheral and cord blood, World Journal of Gastroenterology, 8, 1, 2002. Crossref

  36. Shimamura Hiromune, Cumberland Rachel, Hiroishi Kazumasa, Watkins Simon C., Lotze Michael T., Baar Joseph, Murine Dendritic Cell-Induced Tumor Apoptosis is Partially Mediated by Nitric Oxide, Journal of Immunotherapy, 25, 3, 2002. Crossref

  37. Zöller Margot, Immunotherapy of Cancer by Active Vaccination: Does Allogeneic Bone Marrow Transplantation after Non-Myeloablative Conditioning Provide a New Option?, Technology in Cancer Research & Treatment, 2, 3, 2003. Crossref

  38. Stevanovic Stefan, Identification of tumour-associated t-cell epitopes for vaccine development, Nature Reviews Cancer, 2, 7, 2002. Crossref

  39. Di Nicola Massimo, Gianni A Massimo, Dendritic Cells, Tumori Journal, 1, 6_suppl1, 2002. Crossref

  40. Joshi Bishnu P., Hardie Joseph, Farkas Michelle E., Harnessing Biology to Deliver Therapeutic and Imaging Entities via Cell-Based Methods, Chemistry - A European Journal, 24, 35, 2018. Crossref

  41. Arrighi Jean-François, Hauser Conrad, Chapuis Bernard, Zubler Rudolf H., Kindler Vincent, Long-Term Culture of Human CD34+ Progenitors With FLT3-Ligand, Thrombopoietin, and Stem Cell Factor Induces Extensive Amplification of a CD34−CD14− and a CD34−CD14+ Dendritic Cell Precursor, Blood, 93, 7, 1999. Crossref

  42. Weigel Brenda J., Nath Narender, Taylor Patricia A., Panoskaltsis-Mortari Angela, Chen Wei, Krieg Arthur M., Brasel Kenneth, Blazar Bruce R., Comparative analysis of murine marrow–derived dendritic cells generated by Flt3L or GM-CSF/IL-4 and matured with immune stimulatory agents on the in vivo induction of antileukemia responses, Blood, 100, 12, 2002. Crossref

  43. Arrighi Jean-François, Hauser Conrad, Chapuis Bernard, Zubler Rudolf H., Kindler Vincent, Long-Term Culture of Human CD34+ Progenitors With FLT3-Ligand, Thrombopoietin, and Stem Cell Factor Induces Extensive Amplification of a CD34−CD14− and a CD34−CD14+ Dendritic Cell Precursor, Blood, 93, 7, 1999. Crossref

  44. Dhodapkar Madhav V., Dendritic Cell Vaccines, in Handbook of Cancer Vaccines, 2004. Crossref

  45. Schadendorf D., Nestle F. O., Autologous Dendritic Cells for Treatment of Advanced Cancer — An Update, in Minimal Residual Disease in Melanoma, 158, 2001. Crossref

  46. Abraham Samuel J. K., Terunuma Hiroshi, Dedeepiya Vidyasagar Devaprasad, Premkumar Sumana, Preethy Senthilkumar, An Overview of Treatment for Cervical Cancer with Emphasis on Immune Cell-Based Therapies, in International Manual of Oncology Practice, 2015. Crossref

  47. Pawlowska Anna B., Hashino Satoshi, McKenna Hilary, Weigel Brenda J., Taylor Patricia A., Blazar Bruce R., In vitro tumor-pulsed or in vivo Flt3 ligand–generated dendritic cells provide protection against acute myelogenous leukemia in nontransplanted or syngeneic bone marrow–transplanted mice, Blood, 97, 5, 2001. Crossref

  48. Lu Qianglan, Qi Sun, Li Peishan, Yang Lifang, Yang Shan, Wang Yidan, Cheng Yu, Song Yilin, Wang Siyu, Tan Fengping, Li Nan, Photothermally activatable PDA immune nanomedicine combined with PD-L1 checkpoint blockade for antimetastatic cancer photoimmunotherapy, Journal of Materials Chemistry B, 7, 15, 2019. Crossref

  49. Matzku Siegfried, Z??ller Margot, Specific Immunotherapy of Cancer in Elderly Patients, Drugs & Aging, 18, 9, 2001. Crossref

  50. Pirtskhalaishvili Georgi, Shurin Galina V., Gambotto Andrea, Esche Clemens, Wahl Madeline, Yurkovetsky Zoya R., Robbins Paul D., Shurin Michael R., Transduction of Dendritic Cells with Bcl-xLIncreases Their Resistance to Prostate Cancer-Induced Apoptosis and Antitumor Effect in Mice, The Journal of Immunology, 165, 4, 2000. Crossref

  51. VAN ZANTEN J., HOSPERS G. A. P., HARMSEN M. C., THE T. H., MULDER N. H., DE LEIJ L. F. M. H., Dendritic Cells Present an Intracellular Viral Antigen Derived from Apoptotic Cells and Induce a T-Cell Response, Scandinavian Journal of Immunology, 56, 3, 2002. Crossref

  52. Zhu Yi, Goh Cynthia, Shrestha Annie, Biomaterial Properties Modulating Bone Regeneration, Macromolecular Bioscience, 21, 4, 2021. Crossref

  53. Baar Joseph, Clinical Applications of Dendritic Cell Cancer Vaccines, The Oncologist, 4, 2, 1999. Crossref

  54. Lowenfeld Lea, Mick Rosemarie, Datta Jashodeep, Xu Shuwen, Fitzpatrick Elizabeth, Fisher Carla S., Fox Kevin R., DeMichele Angela, Zhang Paul J., Weinstein Susan P., Roses Robert E., Czerniecki Brian J., Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of HER2pos DCIS Independent of Route: Results of Randomized Selection Design Trial, Clinical Cancer Research, 23, 12, 2017. Crossref

  55. Mercader Maria, Bodner Barbara K., Moser Micheal T., Kwon Pamela S., Park Eugene S. Y., Manecke Ryan G., Ellis Thomas M., Wojcik Eva M., Yang Damu, Flanigan Robert C., Waters W. Bedford, Kast W. Martin, Kwon Eugene D., T cell infiltration of the prostate induced by androgen withdrawal in patients with prostate cancer, Proceedings of the National Academy of Sciences, 98, 25, 2001. Crossref

  56. Li RuYan, Zheng QingHua, Deng QiuPing, Wang Yi, Yang HaoDing, Shen Jian, Liu YingHui, Zhou JiaHong, A Dual Functional Drug Delivery System that Combines Photothermal Therapy and Immunotherapy to Treat Tumors, Molecular Pharmaceutics, 19, 5, 2022. Crossref

  57. Tatsumi T, Takehara T, Yamaguchi S, Sasakawa A, Miyagi T, Jinushi M, Sakamori R, Kohga K, Uemura A, Ohkawa K, Storkus W J, Hayashi N, Injection of IL-12 gene-transduced dendritic cells into mouse liver tumor lesions activates both innate and acquired immunity, Gene Therapy, 14, 11, 2007. Crossref

  58. Butch Anthony W, Kelly Kathleen A, Munshi Nikhil C, Dendritic cells derived from multiple myeloma patients efficiently internalize different classes of myeloma protein, Experimental Hematology, 29, 1, 2001. Crossref

  59. Ferrer Fernando A., Rodriguez Ronald, Gene therapy for urologic cancer, Current Urology Reports, 3, 1, 2002. Crossref

  60. Barrou Benoît, Benoît Gérard, Ouldkaci Mahmoud, Cussenot Olivier, Salcedo Margarita, Agrawal Sudhanshu, Massicard Séverine, Bercovici Nadège, Ericson Mats L., Thiounn Nicolas, Vaccination of prostatectomized prostate cancer patients in biochemical relapse, with autologous dendritic cells pulsed with recombinant human PSA, Cancer Immunology, Immunotherapy, 53, 5, 2004. Crossref

  61. Prabakaran Indira, Menon Chandrakala, Xu Shuwen, Gómez-Yafal Alicia, Czerniecki Brian J., Fraker Douglas L., Mature CD83+ dendritic cells infected with recombinant gp 100 vaccinia virus stimulate potent antimelanoma T cells, Annals of Surgical Oncology, 9, 4, 2002. Crossref

  62. Chang David H., Dhodapkar Madhav V., Dendritic Cells and Immunotherapy for Cancer, International Journal of Hematology, 77, 5, 2003. Crossref

851 Просмотры статей 19 Загрузка статей Метрики
851 ПРОСМОТРЫ 19 ЗАГРУЗКИ 62 Crossref ЦИТАТЫ Google
Scholar
ЦИТАТЫ

Статьи с похожим содержанием:

Immunogenicity of Dendritic-Tumor Fusion Hybrids and Their Utility in Cancer Immunotherapy Critical Reviews™ in Immunology, Vol.27, 2007, issue 5
Rongxiu Zheng, Peter A. Cohen, Suyu Shu, Walter T. Lee
Adoptive CD8+ T-Cell Immunotherapy of AIDS Patients with Kaposi's Sarcoma Critical Reviews™ in Oncogenesis, Vol.6, 1995, issue 3-6
Nancy G. Klimas, Xue-Qin Jin, Roberto Patarca, Mary Ann Fletcher, Dmitry Sandler, Jean Walling, Maria Nieves Garcia, Adam Friedlander
Multiple Defects of Natural Killer Cells in Cancer Patients: Anarchy, Dysregulated Systemic Immunity, and Immunosuppression in Metastatic Cancer Critical Reviews™ in Immunology, Vol.40, 2020, issue 2
Tamara Lah Turnsek, Barbara Breznik, Meng-Wei Ko, Kristin Y. Nguyen, Janko Kos, Kawaljit Kaur, Anahid Jewett, Paul Wong, Emanuela Senjor
PART V. Modulation of Antitumor Vaccine Strategies
Preclinical and Clinical Studies of Recombinant Poxvirus Vaccines for Carcinoma Therapy
Critical Reviews™ in Immunology, Vol.27, 2007, issue 5
Philip M. Arlen, Jeffrey Schlom, Ravi A. Madan, James L. Gulley, James W. Hodge
Combining Functional Electrical Stimulation with Mirror Therapy for the Upper Limb in People with Stroke Critical Reviews™ in Physical and Rehabilitation Medicine, Vol.26, 2014, issue 1-2
Michael S. Kaplan, John Parsons, S. Mathieson

Статьи, принятые к публикации

Identification of a novel five-gene prognostic model for laryngeal cancer associated with mitophagy using integrated bioinformatics analysis and experimental verification Dong Song, Lun Dong, Mei Wang, Xiaoping Gao Function of steroid receptor coactivators (SRCs) in T cells and cancers: Implications for cancer immunotherapy Wencan Zhang, Xu Cao, Hongmin Wu, Xiancai Zhong, Yun Shi, Zuoming Sun Electroacupuncture Alleviates Ischemic Stroke by Activating the mTOR/SREBP1 Pathway Jiawang Lang, Jianchang Luo, Luodan Wang, Wenbin Xu, Jie Jia, Zhipeng Zhao, Boxu Lang KIAA1429 induces the m6A modification of LINC01106 to enhance the malignancy of lung adenocarcinoma cell via JAK/STAT3 pathway Di Xu, Ziming Wang, Fajiu Li Effect of p-estrogen receptor at serine on its function and breast growth Yuan Liang, Junhui Qin, Tiancheng Ma, Tong Yang, Zhenyu Ke, Ruian Wang Mechanistic Insights into Tanshinone IIA in the Amelioration of Post-Thyroidectomy Hypoparathyroidism Xiaoyu Qian, Lin Li, Liang Chen, Chao Shen, Jian Tang MiRNA let-7d-5p alleviates inflammatory responses by targeting Map3k1 and inactivating ERK/p38 MAPK signaling in microglia Fan Fang, Cheng Chen Role of Natural Killer Cells as Cell-Based Immunotherapy in Oral Tumor Eradication and Differentiation Both In Vivo and In Vitro Kawaljit Kaur, Anahid Jewett The Current and Future States of Natural Killer Cell-Based Immunotherapy in Hepatocellular Carcinoma Tu Nguyen, Po-Chun Chen, Janet Pham, Kawaljit Kaur, Steven Raman, Anahid Jewett, Jason Chiang Phillygenin alleviated arthritis through the inhibition of NLRP3 inflammasome and Ferroptosis by AMPK Jianghui Wang, Shufang Ni, Kai Zheng, Yan Zhao, peihong zhang, Hong Chang The value of systemic immune-inflammation index and T cell subsets in the severity and prognosis of sepsis Hao Zhou Efficacy and Nuances of Precision Molecular Engineering for Hodgkin's Disease to a Gene Therapeutic Approach Muhammad Imran Qadir, Bilal Ahmed, Nadir Hussain Serum interleukin 6 and ferritin levels are the independent risk factors for pneumonia in elderly patients Hao Yuan, Jing Tian, Lu Wen Exploration of diagnostic markers associated with inflammation in chronic kidney disease (CKD) based on WGCNA and machine learning Qianjia Wu, Yang Yang, Chongze Lin Clinical significance of serum CTRP3 level in the prediction of cardiac dysfunction and intestinal mucosal barrier dysfunction in patients with severe acute pancreatitis Qiang Shao, Lin Sun The protective effect and mechanism of mild hypothermia on pig lung injury after cardiopulmonary resuscitation Jinlin Ren, Fangfang Zhu, Dongdong Sang, Mulin Cong, Shujuan Jiang Exploring mechanism of Zilongjin in treating lung adenocarcinoma based on network pharmacology combined with experimental verification Kang Zhang, Xiaoqun Chen Gastric Cancer Immune Subtypes and Prognostic Modeling: Insights from Aging-Related Genes Analysis Jian Shen, Minzhe Li Effects of different doses of dexmedetomidine on the prevention of postoperative sleep disturbance and serum neurotransmitter level in patients under general anesthesia Huifei Lu, Fei He, Ying Huang, Zhongliang Wei Identification of key ubiquitination-related genes and their associated with immune infiltration in osteoarthritis based on mRNA-miRNA network Dalu Yuan, Hailiang Shen, Lina Bai, Menglin Li, Qiujie Ye Diagnostic and Prognostic value of peripheral neutrophil CD64 index in elderly patients with community-acquired pneumonia Yan Li, Jing Zhang, Suhang Wang, Jie Cao Identification of Metabolism-Related Prognostic Biomarkers and Immune Features of Head and Neck Squamous Cell Carcinoma Rongjin Zhou, Junguo Wang Downregulation of miR-503-5p promotes the development of pancreatic cancer via targeting cyclin E2 Fei Li, Ying-pei Ling, Pan Wang, Shi-cheng Gu, Hao Jiang, Jie Zhu
Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции Цены и условия подписки Begell House Контакты Language English 中文 Русский Português German French Spain